BeOne — Total revenues
Products & Services · Total revenuesAmgen BeOne — Total revenues remained flat by 0.0% to $66.50M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 2.7%, from $64.75M to $66.50M. Over 2 years (FY 2023 to FY 2025), BeOne — Total revenues shows an upward trend with a 45.9% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase indicates successful market penetration, higher demand, or effective commercial execution for the products within this segment, while a decrease may signal competitive pressure, patent cliffs, or declining market interest.
Detailed definition
This metric represents the total gross revenue generated from products or services associated with the specific strategi...
Peer comparison
Comparable to revenue reporting for specific strategic alliances, joint ventures, or licensed product portfolios at other large-cap biotechnology or pharmaceutical companies.
amgn_segment_beone_total_revenuesHistorical Data
| FY'23 | FY'24 | FY'25 | |
|---|---|---|---|
| Value | $125.00M | $259.00M | $266.00M |
| YoY Change | — | +107.2% | +2.7% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Amgen's beone — total revenues?
- Amgen (AMGN) reported beone — total revenues of $66.50M in Q4 2025.
- How has Amgen's beone — total revenues changed year-over-year?
- Amgen's beone — total revenues increased by 2.7% year-over-year, from $64.75M to $66.50M.
- What is the long-term trend for Amgen's beone — total revenues?
- Over 2 years (2023 to 2025), Amgen's beone — total revenues has grown at a 45.9% compound annual growth rate (CAGR), from $125.00M to $266.00M.
- What does beone — total revenues mean?
- The total sales revenue generated by the specific product line or strategic partnership segment.